Actively Recruiting
Study of Reducing Mycophenolate Mofetil Medication in Kidney Transplant Patients 55 Years and Older Using Trugraf Monitoring
Led by Mayo Clinic · Updated on 2026-03-20
350
Participants Needed
3
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
This research evaluates the safety and effectiveness of reducing the immunosuppressive drug Mycophenolate Mofetil MMF in kidney transplant recipients aged 55 years or older. The study compares patients who continue the standard MMF treatment with those who gradually stop taking it. Researchers aim to understand how withdrawing MMF impacts rejection rates, patient survival, and kidney graft function in this older population. Participants are followed for two years, with blood samples collected to perform specialized tests such as Trugraf, Eurofins TRAC, Trac-ID, Immunophenotyping, and Single Cell RNA sequencing. These tests help predict and monitor transplant rejection and viral infections. At four months post-transplant, eligible participants without rejection signs or donor-specific antibodies are randomly assigned to either continue MMF, withdraw from MMF gradually between months 4 and 10, or remain in a non-randomized group if they do not qualify for randomization. During the study, participants attend visits at 12 and 24 months to complete questionnaires and have medical information and biopsy images collected. Researchers track outcomes including acute rejection, patient deaths, graft failure, kidney function, antibody presence, symptom questionnaires, and urine tests. The study monitors safety events and collects detailed immune cell data to better understand transplant outcomes over the two-year period.
CONDITIONS
Brief Title
Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.
Research Team
N
Nong Yowe Braaten, LPN
E
Esma Kesik, M.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here